Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jiro Miyajima"'
Autor:
Jiro Miyajima, Kentaro Yamada, Shuichi Sato, Shigetaka Suekane, Ichiro Tokubuchi, Kazuhisa Muraishi, Junichi Tani, Yuji Hiromatsu, Yuji Tajiri, Yuko Sasaki, Kei Matsuoka
Publikováno v:
Endocrine Journal. 57:873-880
Sunitinib is a multi-targeted tyrosine kinase inhibitor that is effective for advanced renal cell carcinoma. However, sunitinib often causes hypothyroidism. In this study, we report eight cases with thyroid dysfunction that occurred during sunitinib
Publikováno v:
International Journal of Urology. 4:374-379
Background: Prostate specific membrane antigen (PSM) is a transmembrane glycoprotein that has been described as human prostate specific. It is possible that PSM could be used as a biomarker for staging prostate cancer. Methods: Peripheral blood monon
Autor:
Shigeki Shichijio, Rika Tsunosue, Kazuhiro Masuoka, Hideyo Natori, Makoto Tamai, Jiro Miyajima, Kimitaka Sagawa, Kyogo Itoh
Publikováno v:
Cancer Immunology Immunotherapy. 41:95-103
Autor:
Kosuke Ueda, Fukuko Moriya, Katsuaki Chikui, Kei Matsuoka, Makoto Nakiri, Tokumasa Hayashi, Jiro Miyajima, Shigetaka Suekane
In general, only ≤5% of patients with renal cell carcinoma (RCC) develop paraneoplastic erythropoietin (EPO) overproduction-induced polycythemia. However, a number of reports on EPO-producing RCC are available. The present study aimed to report the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7aa2d6659630352b31084a470908e4
https://europepmc.org/articles/PMC3956246/
https://europepmc.org/articles/PMC3956246/
Autor:
Tatsuo Morita, Kazuhiro Masuoka, Kyogo Itoh, Yasuiki Umezu, Motoko Sakata, Jiro Miyajima, Dai Seito, Hiroshi Matsui, Lazel B. Augustus, Hideyuki Saya, Masanobu Nakao
Publikováno v:
The Kurume Medical Journal. 41:53-63
The immunogenicity of human cancer cells transfected with interleukin 2 (IL-2) gene, a potent vaccine candidate, has not yet been fully investigated. Human renal cell carcinoma (RCC) cells transduced with human IL-2 gene (RCC-IL-2) were investigated
Autor:
Shinshi Noda, Kei Matsuoka, Katsuro Tomiyasu, Mitsunori Matsuo, Jiro Miyajima, Jun Taguchi, Tokumasa Hayashi, Shizuka Iida
Publikováno v:
International Journal of Urology. 8:522-524
Testicular carcinoid is a rare disease accounting for less than 1% of all testicular neoplasms. It rarely manifests symptoms of carcinoid syndrome. Recent reports have noted that only 1.1-3.1% of testicular carcinoid tumors are complicated by carcino
Publikováno v:
The Kurume medical journal. 57(3)
It is well known that the incidence of urinary stones is higher in men than women. Although it is believed that the lower incidence of urinary stones in women is due to a protective effect of estrogen, the mechanisms remain unclear. To clarify the re
Publikováno v:
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 19(6)
Erythropoietin production by renal cell carcinoma (RCC) is reported to be a potential marker for interleukin-2/interferon-alpha-responding tumor. We have investigated whether erythropoietin of RCC cells is involved in the immune recognition by lympho
Autor:
Rika Tsunosue, Kimitaka Sagawa, Kyogo Itoh, Jiro Miyajima, Hideyo Natori, Shigeki Shichijo, Makoto Tamai, Kazuhiro Masuoka
Publikováno v:
Cancer immunology, immunotherapy : CII. 41(2)
The MAGE gene family, encoding tumor-rejection antigens recognized by cytotoxic T lymphocytes, is frequently expressed in human solid cancers. However, its expression in leukemia has not been well studied. We have investigated MAGE gene expression at